Porton Advanced Congratulates Esteemed Partner Lion TCR on IND Approval from NMPA for mRNA TCR-T Cell Therapy GZL-016 in Hepatitis B-Related Liver Cancer
We are thrilled to announce that this week, our esteemed partner Lion TCR has achieved IND approval from China’s NMPA […]